Search Browse Earnings

Cidara Therapeutics, Inc. — SlamSEC

Cidara Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2023

Adj. EBITDA

-$26.9M

FY 2024

Net Income

-$22.9M

FY 2024

EPS (Diluted)

-$5.25

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$35.8M

FY 2024

Total Debt

—

Net Cash

$35.8M

FY 2023

Enterprise Value

—

Debt / EBITDA

1.3x

FY 2023

EV / EBITDA

—

Employees

—